Radiotherapy, or radiation therapy, is a treatment that uses high-energy radiation to damage the DNA of cancer cells. This disruption prevents the cells from dividing and leads to cell death.
Radiotherapy can be used:
- As a primary treatment: Often used alone to treat certain cancers such as lung cancer, cervical cancer, head and neck cancers, laryngeal cancer, lymphoma, and prostate cancer.
- In combination with other therapies: Such as surgery or chemotherapy, for cases like breast cancer, advanced lung cancer, and bladder cancer.
- For palliative care: To relieve pain caused by metastatic cancer.
Radiation works by generating free radicals that damage the DNA in cancer cells beyond repair, ultimately halting their growth and leading to cell death. However, the effect of radiation is not immediate—it takes days or weeks to accumulate sufficient DNA damage.
Types of Radiotherapy
- External Beam Radiation Therapy (EBRT): Radiation is delivered from a machine outside the body.
- Brachytherapy (Internal Radiation): A radiation source is placed directly into or near the tumor. The method chosen depends on factors such as tumor location, size, and stage. Brachytherapy may be used alone or with EBRT or surgery.
Although radiotherapy technology has become more precise, limitations remain—such as resistance caused by cancer stem cells and microRNAs involved in DNA repair.
Radiosensitizers: Enhancing the Effectiveness of Radiotherapy
Radiosensitizers increase the sensitivity of cancer cells to radiation, enhance radiation-induced cell death, inhibit DNA repair, and target cancer stem cells.
- Hyperbaric Oxygen Therapy (HBOT) and Ozone Therapy
- Radiation is more effective in oxygen-rich environments because oxygen enhances free radical formation.
- Tumors often lack oxygen, allowing cells to resist radiation.
- HBOT and ozone therapy increase oxygen supply to tumors, improving radiation efficacy.
- Ozone therapy also stimulates immune response and increases free radicals that harm cancer cells.
- Clinical studies show that combining HBOT with whole-brain radiation significantly improves overall outcomes and quality of life in patients with brain metastases.
- Natural Phytochemicals (Flavonoids)
Natural plant compounds act as radiosensitizers by:
- Inhibiting carcinogenic pathways,
- Reducing inflammation,
- Inducing apoptosis,
- Overcoming radiation resistance, and
- Targeting cancer stem cells.
Key phytochemicals include:
- Curcumin (turmeric)
- Resveratrol/Stilbene (red grape skin)
- Genistein (soybeans)
- Quercetin (onions)
- Catechins/EGCG (green tea)
- Berberine (golden seal)
These compounds modulate multiple molecules and pathways involved in cancer progression, angiogenesis, inflammation, and radiation resistance. Lab and animal studies show improved effectiveness when combined with radiation in cancers such as brain, nasopharyngeal, prostate, pancreatic, breast, and melanoma.
Clinical trials confirm benefits in breast, prostate, pancreatic, colon, and ovarian cancers. These compounds can be administered orally or intravenously, have minimal side effects, and protect normal cells—thus acting as both radiosensitizers and radioprotectors.
- Repurposed Drugs
Medications originally developed for other diseases (e.g., diabetes, heart disease, infections) have been found to have anticancer properties and are safe due to existing clinical data.
Notable repurposed drugs studied with radiation include:
- Metformin (diabetes)
- Mebendazole (anti-parasitic)
- Enoxaparin (anticoagulant)
- Aspirin (anti-inflammatory)
- Simvastatin (lipid-lowering)
- Valproic acid (anti-epileptic)
Clinical studies show that these drugs enhance radiotherapy outcomes.
- Low-Dose Chemotherapy (Metronomic Chemotherapy)
This strategy uses low, frequent doses of chemotherapy with different mechanisms than high-dose chemotherapy:
- Enhances immune function,
- Inhibits angiogenesis,
- Induces apoptosis without causing drug resistance.
A study on inoperable, locally advanced lung cancer showed that concurrent low-dose chemotherapy and radiation improved tumor shrinkage and survival.
- Local Hyperthermia
This technique heats tumor tissue to 39–45°C using specialized equipment that targets tumors without damaging surrounding tissues.
Hyperthermia:
- Stimulates immune activity,
- Enhances blood flow, and
- Increases cancer cell sensitivity to radiation, especially in cancer stem cells.
Reports show that combining hyperthermia with radiation benefits patients with recurrent or advanced breast cancer, leading to better disease control and increased survival.
- High-Dose Intravenous Vitamin C Therapy
Vitamin C administered intravenously has several anticancer effects:
- Damages cancer cell DNA,
- Inhibits cell division,
- Induces apoptosis, and
- Disrupts signaling pathways.
Lab studies reveal that IV high-dose vitamin C, unlike oral supplements, sensitizes cancer cells (e.g., breast, leukemia, brain) to radiation and reduces resistance.
Clinical examples:
- In advanced pancreatic cancer, combining IV vitamin C with radiation and chemotherapy shrank tumors enough for surgical removal.
- In glioblastoma, the same combination stabilized disease and improved survival.
Conclusion: Holistic and Personalized Integrative Care
Integrative cancer treatment not only boosts radiotherapy through radiosensitizers and novel strategies but also emphasizes holistic, personalized patient care. This approach aims to enhance survival with quality of life, combining modern science with complementary modalities for comprehensive support.
- T.Ruba and Dr.R.Tamilselvi. Asian Journal of Applied Science and Technology (AJAST) Volume 2, Issue 1, Pages 77-86, 2018. Radiosensitizers and Radioprotectors for Effective Radiation Therapy– A Review
- Arif Malik, Misbah Sultana, et al. Hindawi Publishing Corporation Analytical Cellular Pathology Volume 2016, Article ID 6146595, 8 pages http://dx.doi.org/10.1155/2016/6146595. Role of Natural Radiosensitizers and Cancer Cell Radioresistance: An Update.
- Alexander MS, Wilkes JG, Schroeder SR, Buettner GR, Wagner BA, Du J, et al. Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancreatic Cancer. Cancer Res. 2018 Dec 15;78(24):6838–51.
- Dominika Komorowska, Tomasz Radzik, et al. Int. J. Mol. Sci. 2022, 23, 10627. https://doi.org/10.3390/ijms231810627. Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol
- Bimal Prasad Jit, Biswajita Pradhan, et al. Antioxidants 2022, 11, 49. https://doi.org/10.3390/antiox11010049. Phytochemicals: Potential Therapeutic Modulators of Radiation Induced Signaling Pathways
- Mohammad K Khan, MD Ph.D., Tahseen Nasti, PhD et al, Cancer J. 2019 ; 25(2): 106–115. doi:10.1097/PPO.0000000000000369. Repurposing Drugs for Cancer Radiotherapy: Early successes and emerging opportunities
- Sabah Nisar a, Tariq Masoodi b, et al. Biomedicine & Pharmacotherapy 154 (2022) 113610. Natural products as chemo-radiation therapy sensitizers in cancers
- Qiaozhen Kang, Xiaomiao Zhang, et al. Food and Chemical ToxicologyVolume 133, November 2019, 110807. EGCG enhances cancer cells sensitivity under 60Coγ radiation based on miR-34a/Sirt1/p53
- Vincent Anku, MD. J Natl Med Assoc. 2000;92:105-1 15.Successful Low-dose concurrent chemotherapy and radiation for locally advanced or inoperable Non-Small Cell Lung Carcinoma (NSCLC): A report of six cases.
- Tamer Refaat, Sean Sachdev, et al.The Breast Volume 24, Issue 4, August 2015, Pages 418-425. Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer
- Azzaya Sengedorj, Michael Hader, et al. Current Stem Cell Reports (2022) 8:129–138. Interaction of Radiotherapy and Hyperthermia with the Immune System: a Brief Current Overview
- Somayeh Khazaei, Linn Nilsson, et al. Oncotarget, 2022, Vol. 13, pp: 439-453. Impact of combining vitamin C with radiation therapy in human breast cancer: does it matter?
- Jing Tao, Zhaoyu Gao, et al. Experimental And Therapeutic Medicine 17: 465-471, 2019. Therapeutic effect of combined hyperbaric oxygen and radiation therapy for single brain metastasis and its influence on osteopontin and MMP‑9
- Jung-Mu Hur, Dongho Kim, Toxicol. Res. Vol. 26, No. 2, pp. 109-115 (2010). Berberine Inhibited Radioresistant Effects and Enhanced Anti-Tumor Effects in the Irradiated-Human Prostate Cancer Cells
